ASP Isotopes (NASDAQ:ASPI) Stock Price Down 5.3% Following Insider Selling

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shares traded down 5.3% during mid-day trading on Tuesday following insider selling activity. The company traded as low as $5.38 and last traded at $5.4050. 1,337,331 shares were traded during trading, a decline of 70% from the average session volume of 4,482,298 shares. The stock had previously closed at $5.71.Specifically, CFO Heather Kiessling sold 80,000 shares of the company's stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the completion of the sale, the chief financial officer directly owned 732,500 shares in the company, valued at $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Wall Street Analyst Weigh InA number of equities analysts recently commented on the company. Canaccord Genuity Group reiterated a "buy" rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Monday, November 24th. Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a report on Monday, December 22nd. Loop Capital set a $15.00 price target on shares of ASP Isotopes in a research report on Monday, October 27th. Finally, Cantor Fitzgerald started coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an "overweight" rating and a $13.00 price objective for the company. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $13.00.Check Out Our Latest Analysis on ASPIASP Isotopes Trading Down 4.8%The firm has a market capitalization of $602.42 million, a PE ratio of -4.17 and a beta of 3.42. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. The business has a fifty day moving average price of $7.31 and a two-hundred day moving average price of $8.51. ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The company had revenue of $4.89 million during the quarter, compared to analysts' expectations of $2.25 million. ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. Analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year. Institutional Trading of ASP IsotopesA number of institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. Rovida Advisors Inc. acquired a new position in ASP Isotopes during the second quarter worth $16,148,000. Rovida Investment Management Ltd raised its holdings in shares of ASP Isotopes by 528.6% in the 2nd quarter. Rovida Investment Management Ltd now owns 2,200,000 shares of the company's stock valued at $16,148,000 after buying an additional 1,850,000 shares during the period. Exchange Traded Concepts LLC acquired a new position in ASP Isotopes during the 2nd quarter worth about $9,593,000. Marshall Wace LLP boosted its holdings in ASP Isotopes by 3,669.1% during the 3rd quarter. Marshall Wace LLP now owns 1,279,121 shares of the company's stock valued at $12,305,000 after acquiring an additional 1,245,184 shares during the period. Finally, Vanguard Group Inc. grew its position in ASP Isotopes by 37.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company's stock valued at $43,451,000 after acquiring an additional 1,241,024 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company's stock. About ASP Isotopes (Get Free Report)ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.See AlsoFive stocks we like better than ASP IsotopesAmericans can target 100%+ wins during “Operation Motherlode”Trump’s new AI budget just passed — one stock could soarWall Street Stockpicker Names #1 Stock of 2026Chilling warning from legendary investorBuy this $2 Gold Stock Before January 1, 2026This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in ASP Isotopes Right Now?Before you consider ASP Isotopes, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.While ASP Isotopes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here